$0.30
+0.00 (+1.45%)
Open$0.31
Previous Close$0.30
Day High$0.31
Day Low$0.30
52W High$11.80
52W Low$0.25
Volume—
Avg Volume38.2K
Market Cap126.36M
P/E Ratio—
EPS$-0.28
SectorPharmaceuticals
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.44B | 1.89B | 106.35M |
| Net Income | -82,731,621 | -97,932,998 | 12.42M |
| Profit Margin | -5.8% | -5.5% | 11.7% |
| EBITDA | 38.61M | 48.24M | 22.69M |
| Free Cash Flow | — | — | 8.29M |
| Rev Growth | -24.0% | -24.0% | +7.5% |
| Debt/Equity | — | — | 0.19 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |